Question 1

What are the potential side effects of Ribociclib when combined with radiation therapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer clinical trial (NCT05996107). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this treatment affect my overall cancer care plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer clinical trial (NCT05996107). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any specific tests or monitoring I will need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer clinical trial (NCT05996107). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects or complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer clinical trial (NCT05996107). Contact the study team or your healthcare provider for specific answers.

Question 5

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer clinical trial (NCT05996107). Contact the study team or your healthcare provider for specific answers.

Question 6

What is the expected duration of my participation in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer clinical trial (NCT05996107). Contact the study team or your healthcare provider for specific answers.

What this study is about